EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures

Jiayu Leong iD, Wen Qin Tang, Jake Chng, Wei Xuan Ler, Norhaizat Abdul Manan, Lyn Chiin Sim, Zi Ying Zheng, Wei Zhang, Ian Walsh, Gerben Zijlstra, Maarten Pennings, Say Kong Ng

Biotechnology Journal · 2024-07 · 19 (7)

DOI: 10.1002/biot.202400092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 10.07.2024. Verfasst von Jiayu Leong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore. Hauptthemen laut MEDLINE: Cricetulus, Antibodies, Monoclonal, Bioreactors, Biomass. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous manufacturing enables high volumetric productivities of biologics such as monoclonal antibodies. However, it is challenging to maintain both high viable cell densities and productivities at the same time for long culture durations. One of the key controls in a perfusion process is the perfusion rate which determines the nutrient availability and potentially controls the cell metabolism. Cell Specific Perfusion Rate (CSPR) is a feed rate proportional to the viable cell density while Biomass Specific Perfusion Rate (BSPR) is a feed rate proportional to the biomass (cell volume multiply by cell density). In this study, perfusion cultures were run at three BSPRs in the production phase. Low BSPR favored a growth arresting state that led to gradual increase in cell volume, which in turn led to an increase in net perfusion rate proportional to the increase in cell volume. Consequently, at low BSPR, while the cell viability and cell density decreased, high specific productivity of 55 pg per cell per day was achieved. In contrast, the specific productivity was lower in bioreactors operating at a high BSPR. The ability to modulate the cell metabolism by using BSPR was confirmed when the specific productivity increased after lowering the BSPR in one of the bioreactors that was initially operating at a high BSPR. This study demonstrated that BSPR significantly influenced cell growth, metabolism, and productivity in cultures with variable cell volumes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CricetulusAntibodies, MonoclonalBioreactorsBiomassCell Culture TechniquesBiosimilar PharmaceuticalsCHO CellsAnimalsCell SurvivalCell CountCell ProliferationPerfusion

Stichwörter der Autor:innen

BSPRTFFbiosimilarcontinuous biomanufacturinghigh cell densityperfusion bioreactor

Substanzen

Antibodies, MonoclonalBiosimilar Pharmaceuticals

Autor:innen und Institutionen

  • Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
  • BiosanaProcess Pte. Ltd., Singapore, Republic of Singapore.
  • Sartorius Stedim Netherlands B.V., Rotterdam, The Netherlands.
  • BiosanaPharma, Leiden, The Netherlands.

ORCID-Profile: Jiayu Leong

Zitieren

APA

Leong, J., Tang, W. Q., Chng, J., Ler, W. X., Manan, N. A., Sim, L. C., Zheng, Z. Y., Zhang, W., Walsh, I., Zijlstra, G., Pennings, M., & Ng, S. K. (2024). Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures. Biotechnology Journal, 19(7). https://doi.org/10.1002/biot.202400092

Vancouver

Leong J, Tang WQ, Chng J, Ler WX, Manan NA, Sim LC, et al. Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures. Biotechnology Journal. 2024;19(7). doi:10.1002/biot.202400092

BibTeX
@article{Leong2024,
  author = {Leong, Jiayu and Tang, Wen Qin and Chng, Jake and Ler, Wei Xuan and Manan, Norhaizat Abdul and Sim, Lyn Chiin and Zheng, Zi Ying and Zhang, Wei and Walsh, Ian and Zijlstra, Gerben and Pennings, Maarten and Ng, Say Kong},
  title = {Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures},
  journal = {Biotechnology Journal},
  year = {2024},
  volume = {19},
  number = {7},
  doi = {10.1002/biot.202400092}
}
Kostenlos starten →